Rankings
▼
Calendar
BMRN Q2 2016 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena
BMRN
BioMarin Pharmaceutical Inc.
$12B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$300M
Gross Profit
$249M
82.8% margin
Operating Income
-$573M
-190.9% margin
Net Income
-$419M
-139.6% margin
EPS (Diluted)
$-2.61
QoQ Revenue Growth
+26.8%
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$72M
Stock-Based Comp.
$34M
Balance Sheet
Total Assets
$3.1B
Total Liabilities
$1.2B
Stockholders' Equity
$1.9B
Cash & Equivalents
$306M
Revenue Segments
Product One
$107M
36%
Product Three
$90M
30%
Product Two
$78M
26%
Product Four
$19M
6%
Product Five
$4M
1%
Geographic Segments
UNITED STATES
$126M
42%
Europe
$65M
22%
Rest Of World
$60M
20%
Latin America
$50M
17%
← FY 2016
All Quarters
Q3 2016 →
